JPL Wealth Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
JPL Wealth Management's BBIO Position: Q3 2026 in Review
JPL Wealth Management sold out of BridgeBio Pharma (BBIO) in Q3 2026, closing a stake of 25 shares — an estimated $1.86K sold.
JPL Wealth Management first reported a position in BBIO in Q3 2025 and held it in 3 quarters. The position peaked at $1.86K in Q2 2026. 471 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- JPL Wealth Management reported no remaining BridgeBio Pharma position as of Q3 2026 after selling out during the quarter.
- JPL Wealth Management sold 25 BridgeBio Pharma shares in Q3 2026, an estimated $1.86K.
- JPL Wealth Management first reported a position in BridgeBio Pharma in Q3 2025 and held it in 3 quarters.
- JPL Wealth Management's BridgeBio Pharma position peaked at $1.86K in Q2 2026.
- 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on JPL Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.